Amersham Licenses Tagging and Imaging Systems to Lilly

Nov 07, 2003

NEW YORK, Nov. 7 (GenomeWeb News) - Amersham announced today that Eli Lilly has licensed the rights to Amersham's Aequorea Victoria Green Fluorescent Protein and has secured rights to operate under Biolmage's Redistribution patent portfolio for monitoring intracellular signaling pathways.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Breaking News

The Scan

Closely Intertwined

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Little From Here and There

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

All the Arms for Hugging

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.

This Week in Science

In Science this week: in vitro generation of human reproductive cells, and more.

Main menu